Hello, and welcome to the DeBosch Lab! We study hepatic and enterocyte determinants of metabolic syndrome and non-alcoholic fatty liver disease.
- The DeBosch Lab was just awarded a renewal on its Diabetes Research Center Grant to continue studying molecular physiological mechanisms of trehalose-induced thermogenesis!
- Allyson's paper, Enhanced Hepatic PPARα Activity Links GLUT8 Deficiency to Augmented Peripheral Fasting Responses in Male Mice, has been accepted for publication in Endocrinology!
- Paul Hruz and Brian DeBosch were named winners of the 2018 LEAP Inventors Challenge at Washington University for their invention, Selective Novel Treatment of Fatty Liver Disease
- Yiming Zhang (Technician II) just got a paper in press at Autophagy: "Transcription Factor EB (TFEB)-dependent Induction of Thermogenesis by the Hepatocyte Solute Carrier 2A (SLC2A) inhibitor, Trehalose".
- Allyson Mayer (DBBS Student, Developmental, Stem Cell & Regenerative Medicine) will defend her thesis in May 2018 (5 year completion time!). She completes her time in the DeBosch Lab as an Spencer and Ann Olin Fellow, and a National Science Foundation Graduate Research Fellowship Awardee.
- Dr. DeBosch was just awarded a grant from the Department of Defense Discovery Award program
- Emily Feng, BS (WUSTL ArtSci 2016), DeBosch Lab Alum, enrolled at Kansas University School of Medicine
- Oyin Adenekan (WUSTL ArtSci 2020) was awarded an HHMI undergraduate research fellowship (2018)
- The DeBosch Lab's discoveries: Featured in Science Signaling's 2016 "Signaling Breakthroughs of the Year" (2017)